Poly (ortho ester) matrices for controlled release of the antitumour agent 5-fluorouracil
Authors:
- Len W. SeymourLSLen W. Seymour
- Ruth DuncanRDRuth Duncan
- Julie DuffyJDJulie Duffy
- S.Y. NgSNS.Y. Ng
- Jorge HellerJHJorge Heller
- 1 September 1994
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 31 (2) , 201-206
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymersJournal of Neurosurgery, 1992
- Phase II Trial of 7-Day Continuous 5-Fluorouracil Infusion in the Treatment of Advanced Colorectal CarcinomaOncology, 1992
- Recent developments in the synthesis and utilization of poly (ortho esters)Journal of Controlled Release, 1991
- Protracted Intravenous Infusion of 5-Fluorouracil in Combination TreatmentsActa Oncologica, 1991
- Controlled release of 5-fluorouracil from linear poly(ortho esters)Journal of Controlled Release, 1990
- 5-Fluorouracil and folinic acid: interesting biochemistry or effective treatment?British Journal of Cancer, 1989
- A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.Journal of Clinical Oncology, 1989
- Brain biocompatibility of a biodegradable, controlled‐release polymer in ratsJournal of Biomedical Materials Research, 1989
- Biocompatibility of a Biodegradable, Controlled-Release Polymer in the Rabbit BrainSelective Cancer Therapeutics, 1989
- Continuous 5-Fluorouracil Infusion in Advanced Gastric CarcinomaAmerican Journal of Clinical Oncology, 1988